Comparison Between Linagliptin and Canagliflozin Effect on Inflammatory Markers, CD34+ Cell Gene Expression and Urine Exosomes in Type 2 Diabetes Subjects

Authors

Seshagiri R. Nandula, George Washington University
Rajesh Janapala, George Washington University
Sabyasachi Sen, George Washington University

Document Type

Journal Article

Publication Date

5-3-2021

Journal

Journal of the Endocrine Society

Volume

5

Issue

Supplement 1

DOI

10.1210/jendso/bvab048.650

APA Citation

Nandula, S. R., Janapala, R., & Sen, S. (2021). Comparison Between Linagliptin and Canagliflozin Effect on Inflammatory Markers, CD34+ Cell Gene Expression and Urine Exosomes in Type 2 Diabetes Subjects. Journal of the Endocrine Society, 5 (Supplement 1). http://dx.doi.org/10.1210/jendso/bvab048.650

Peer Reviewed

1